C. Barbara

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

Alfredo Falcone, Sergio Ricci, I. Brunetti et al. · Journal of Clinical Oncology · 2007 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila et al. · JAMA Oncology · 2018 · 420 citations · Full text

Medicine, Oncology, Pharmacology +17

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

Gianluca Masi, Lisa Salvatore, Luca Boni et al. · Annals of Oncology · 2015 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

An Improved HPLC Method for Therapeutic Drug Monitoring of Daunorubicin, Idarubicin, Doxorubicin, Epirubicin, and Their 13-Dihydro Metabolites in Human Plasma

Stefano Fogli, Romano Danesi, Federico Innocenti et al. · Therapeutic Drug Monitoring · 1999 · 74 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity

Guido Bocci, C. Barbara, Francesca Vannozzi et al. · Clinical Pharmacology & Therapeutics · 2006 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +15